| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | -8.1% |
| Cost of Revenue | $681.9M | -0.7% |
| Gross Profit | $323.6M | -20.5% |
| R&D Expense | $165.7M | +18.4% |
| SG&A Expense | $63.8M | +4.5% |
| Operating Income | -$75.5M | -293.7% |
| Interest Expense | $4.7M | -24.7% |
| Pre-tax Income | -$67.7M | -296.6% |
| Income Tax | -$14.6M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $222.7M | -0.5% |
| Accounts Receivable | $91.5M | +18.8% |
| Inventory | $106.3M | -16.4% |
| Current Assets | $482.6M | -20.4% |
| Total Assets | $968.0M | -10.1% |
| Current Liabilities | $279.1M | +1.1% |
| Long-term Debt | $92.6M | -34.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.9M | -671.8% |
| Capital Expenditures | $1.5M | -55.9% |
| Investing Cash Flow | $121.9M | +1553.3% |
| Financing Cash Flow | -$90.4M | +47.8% |
| Free Cash Flow | -$34.4M | -1594.9% |
| -359.5% |
| Net Income | -$53.2M | -284.4% |
| EPS (Basic) | -$0.35 | -294.4% |
| EPS (Diluted) | -$0.35 | -294.4% |
| Total Liabilities |
| $412.1M |
| -11.4% |
| Stockholders' Equity | $555.8M | -9.1% |